Recruiting Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs. NCT07165132 Conditions Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +24 more Locations Research Facility — Iowa City, Iowa, United States Research Facility — Lexington, Kentucky, United States Research Facility — St Louis, Missouri, United States Research Facility — St Louis, Missouri, United States View more locations Show fewer locations Loading locations... View Trial Details
Recruiting Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy NCT05477576 Conditions Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +22 more Locations Research Facility — Phoenix, Arizona, United States Research Facility — Duarte, California, United States Research Facility — Irvine, California, United States Research Facility — Los Angeles, California, United States View all 54 locations View more locations Show fewer locations Loading locations... View Trial Details
Recruiting Influence of Tumour and Patient's Related Factors on the Response to Medical Treatments in Well Differentiated GEP-NENs NCT06356467 Conditions GEP-NET, Gastro-enteropancreatic neuroendocrine tumor, Neoplasms, +5 more Locations IRCCS OSpedale San Raffaele — Milan, Italy View Trial Details
Enrolling by Invitation Nal-IRI (ONIVYDE® ) and Carboplatin in Patients With Advanced or Metastatic GEP-NET NCT05385861 Conditions GEP-NET, Gastro-enteropancreatic neuroendocrine tumor Locations Chang-Gung Memorial Hospital, Kaohsiung — Kaohsiung City, Taiwan Kaohsiung Medical University Chung-Ho Memorial Hospital — Kaohsiung City, Taiwan Chang Gung Memorial Hospital (Lin-Kou), — Linkou District, Taiwan China Medical University Hospital — Taichung, Taiwan View more locations Show fewer locations Loading locations... View Trial Details
